Abbott Laboratories
Abbott Launches New Protein Powder and Offers More Than Dividends
·Consolidated from 3 sources
Abbott Laboratories is expanding its nutrition offerings with a new Ensure Max Protein powder. The company is also highlighting its broader value proposition beyond its dividend appeal, suggesting it offers investors more than just income.
Abbott Laboratories has introduced a new iteration of its Ensure Max Protein powder, now featuring creatine and HMB. This product expansion aims to cater to consumers seeking enhanced protein support for muscle health and recovery.
Coverage today also suggests that Abbott Laboratories is more than just a dividend stock. While the company's dividend is a draw for some investors, reports indicate that its overall business strategy and product innovation present a more comprehensive investment case. This perspective encourages a look beyond the immediate yield to understand the company's broader market position and growth potential.
This focus on diversified revenue streams and product development, such as the new protein powder, underscores Abbott's strategy to appeal to a wide range of consumers and investors. The company continues to leverage its established brands while exploring new avenues for growth in the health and wellness sector.
Sources
This recap was generated by consolidating the public headlines below.
- Abbott Laboratories is More than a Dividend Stock. Here’s Why.Oct 11, 2026
- AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.Oct 11, 2026
- Abbott Laboratories (ABT) Debuts Ensure Max Protein Powder With Creatine And HMBOct 11, 2026